StockData
Biofrontera Inc. logo

Biofrontera Inc. (BFRI) stock

BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$0.59+0.02 (+4.09%)

Close on Nov 17, 2026Market cap $8.81MP/E –Yield –

Biofrontera price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Biofrontera's price to book ratio was 2.2× on Nov 11, 2026, against 10.6× a year earlier. Over the last 4 years it ranged from 0.3× to 20.4×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−18.2
2025Jul 31, 202520.4×+19.1
2024Dec 31, 20241.3×−2.4
2023Dec 29, 20233.6×+2.7
2022Dec 30, 20221.0×−5.1
2021Oct 29, 20216.1×–

More Biofrontera figures

See a number that looks wrong?